About Aumgene Biosciences
Aumgene Biosciences is a company based in Surat (India) founded in 2004 by Anand Daga. Aumgene Biosciences has raised $12.93 thousand across 1 funding round from investors including Paragbarter. The company has 56 employees as of April 09, 2024. Aumgene Biosciences offers products and services including Enzymes, Probiotics, Agribiotech Products, Contract Fermentation, and Contract Research. Aumgene Biosciences operates in a competitive market with competitors including Charles River Laboratories, Cytel, Ginkgo Bioworks, LabCorp and Precision Medicine Group, among others.
- Headquarter Surat, India
- Employees 56 as on 09 Apr, 2024
- Founders Anand Daga
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aumgene Biosciences Private Limited
- Date of Incorporation 26 May, 2004
- Jurisdiction Surat, Gujarat, India
-
Annual Revenue
$4.36 M (USD)29.16as on Mar 31, 2023
-
Net Profit
$811.16 K (USD)55.04as on Mar 31, 2023
-
EBITDA
$1.48 M (USD)37.24as on Mar 31, 2023
-
Total Equity Funding
$12.93 K (USD)
in 1 rounds
-
Latest Funding Round
$12.93 K (USD), Seed
Feb 20, 2008
- Investors
-
Employee Count
56
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aumgene Biosciences
Aumgene Biosciences offers a comprehensive portfolio of products and services, including Enzymes, Probiotics, Agribiotech Products, Contract Fermentation, and Contract Research.
Manufactured enzymes for industrial and biological applications.
Probiotics for health, agriculture, and microbial enhancement.
Biofertilizers to improve soil and crop productivity.
Fermentation services for external manufacturing needs.
Research services for enzyme and biologic development.
Testing services to analyze enzyme properties and efficacy.
Drying processes for product formulation and preservation.
Funding Insights of Aumgene Biosciences
Aumgene Biosciences has successfully raised a total of $12.93K through 1 strategic funding round. The most recent funding activity was a Seed round of $12.93 thousand completed in February 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aumgene Biosciences
Aumgene Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Paragbarter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Aumgene Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aumgene Biosciences
Investment portfolio details for Aumgene Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aumgene Biosciences
Detailed financials for Aumgene Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aumgene Biosciences Comparisons
Peer comparison for Aumgene Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aumgene Biosciences
Aumgene Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, Ginkgo Bioworks, LabCorp and Precision Medicine Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Pendulum is focused on developing advanced probiotic solutions.
|
Detailed competitors of Aumgene Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aumgene Biosciences
Complete news archive for Aumgene Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aumgene Biosciences
Aumgene Biosciences was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Aumgene Biosciences is headquartered in Surat, India. It is registered at Surat, Gujarat, India.
Aumgene Biosciences is a funded company, having raised a total of $12.93K across 1 funding round to date.
As of Apr 09, 2024, the latest employee count at Aumgene Biosciences is 56.
Annual revenue of Aumgene Biosciences is $4.36M as on Mar 31, 2023.
Aumgene Biosciences was founded in 2004 in Surat, India, within the biotechnology sector. Contract research and manufacturing services for enzymes, probiotics, and agribiotech products are offered to pharmaceutical and biotechnology companies. Facilities for high-throughput screening of microbial strains, fermentation process development, and purification of enzymes and biologics are maintained. Toll manufacturing and related fermentation services are also provided across operations.
Aumgene Biosciences's top competitors include LabCorp, Charles River Laboratories and Pendulum.
Aumgene Biosciences offers Enzymes, Probiotics, Agribiotech Products, Contract Fermentation, and 3 more products and services.
Aumgene Biosciences has 1 investor. Key investors include Paragbarter.
The valuation of Aumgene Biosciences is $152.12K as of Feb 2008.